University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat

Simple item page
dc.contributor.authorJohansson, Hanna Katarina Lilith
dc.contributor.authorSvingen, Terje
dc.contributor.authorBoberg, Julie
dc.contributor.authorFowler , Paul A
dc.contributor.authorStead, David
dc.contributor.authorVinggaard, Anne Marie
dc.contributor.authorFilis, Panagiotis
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2020-05-20T07:20:03Z
dc.date.available2020-05-20T07:20:03Z
dc.date.issued2020-04
dc.descriptionOpen Access via Springer Compact Acknowledgements This work was funded by the Ministry of Environment and Food of Denmark, and by a grant from the European Commission 7th Framework Program CONTAMED (Contaminant mixtures and human reproductive health-novel strategies for health impact and risk assessment of endocrine disrupters, grant agreement no.: 215202), as well as the Medical Research Council (UK) (MR/L010011/1 to PAF) and the EU Horizon 2020 project FREIA (Grant Number 825100). We would like to thank Heidi Letting, the Animal facilities at DTU food, and the University of Aberdeen Proteomics Core Facility for their support and assistance in this work.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent1525248
dc.identifier158359947
dc.identifier26e94702-63f6-4365-b76f-84d1865ff501
dc.identifier32221642
dc.identifier000521900800001
dc.identifier85082429722
dc.identifier.citationJohansson, H K L, Svingen, T, Boberg, J, Fowler , P A, Stead, D, Vinggaard, A M & Filis, P 2020, 'Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat', Archives of Toxicology, vol. 94, pp. 1241-1250. https://doi.org/10.1007/s00204-020-02697-3en
dc.identifier.doi10.1007/s00204-020-02697-3
dc.identifier.issn0340-5761
dc.identifier.otherSCOPUS: 85082429722
dc.identifier.otherORCID: /0000-0001-9268-5868/work/76974325
dc.identifier.otherORCID: /0000-0002-4831-9075/work/79059739
dc.identifier.urihttps://hdl.handle.net/2164/14335
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85082429722&partnerID=8YFLogxKen
dc.identifier.vol94en
dc.language.isoeng
dc.relation.ispartofArchives of Toxicologyen
dc.subjectovaryen
dc.subjectproteomeen
dc.subjectendocrine disruptionen
dc.subjectovarian dysgenesis syndromeen
dc.subjectAOPen
dc.subjectR Medicineen
dc.subjectHealth, Toxicology and Mutagenesisen
dc.subjectToxicologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/L010011/1en
dc.subjectEuropean Commissionen
dc.subject215202en
dc.subject825100en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleCalretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the raten
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Johansson_etal_MT_CalretininIsANovel_VOR.pdf
Size:
1.45 MB
Format:
Adobe Portable Document Format
Download

Collections

All research